Minerva Surgical, Inc. (UTRS) Q1 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Today's conference is scheduled to begin shortly. Please continue to stand by and thank you for your patience. Thank you. Thank you. Thank you. Good day, and thank you for standing by. Welcome to the Minerva Surgical first quarter 2022 earnings call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during the session, you will need to press star one on your telephone. Please be advised that today's conference is being recorded. If you require any further assistance, please press star zero. I would now like to hand the conference over to your speaker today, Caroline Corner with Investor Relations. Please go ahead. Thank you, Operator. Welcome to Minerva's first quarter 2022 earnings call. Joining me on today's call are Dave Clapper, President and Chief Executive Officer, and Joel Young, Chief Financial Officer. This call will provide forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical fact should be considered forward-looking statements, including statements regarding the markets in which Minerva Surgical operates, trends and expectations for Minerva's products and technology, trends and demands for Minerva's products, Minerva's expected financial performance, expenses, and position in the market and outlook for fiscal year 2022, and the impact of COVID-19 and its variance on Minerva's operations and Minerva's customers' operations. These statements neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause ISOR results, performance, or achievements to differ materially from any results, perform...